MED BIO WARFARE DEF READINESS FOR US FORCES IN OPER DES SHIE

File: 120396_sep96_decls47_0001.txt
Page: 0001
Total Pages: 2

Subject: MED BIO WARFARE DEF READINESS FOR US FORCES IN OPER DES SHIE    

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003204

Folder Title: MEDICAL BIOLOGICAL WARFARE DEFENSE READINESS FOR US FORCES IN ODS                               

Document Number:          1

Folder SEQ  #:         10






                                                    UNCLASSIFIED




                                    INFORMATION PAPER


                                                                 5 Apr 91
                                                                  DASG-HCD

         SUBJECT: Medical Biological warfare (BW) Defense Readiness for
         U.S. Forces in Operation Desert shield/Storm (U)

         1. (U) Purpose: To provide information on the medical BW defense
         readiness for U.S. Forces in operation Desert Shield/Storm.

         2. @ Facts:

             a.  @ From 1988 to the start of operation Desert Shield,
         peace was breaking out. Although stockpiling of BW vaccines was
         contrary to the world political environment, it had to be done. in
         1988 the Army Medical Department (AMEDD) initiated a BW vaccine
         production and stockpiling program using the limited industrial
         base capability in CONUS. Contracts for production of anthrax
         vaccine and botulinum toxoid were established with Michigan
         Department of Public Health in FY88 and FY89, respectively, by the
         AMEDD. Other BW vaccines such as Venezuelan Equine Encephalitis
         became part of the stockpile when it transitioned from Milestone
         III at the U.S. Army Medical Research and Development Command.

             b. @ Anthrax and botulinum vaccines were in production when
         Operation Desert Shield occurred. only limited stocks had been
         accumulated, and production surge in Aug 90 could not meet all
         requirements because limited industrial base and strict Food and
         Drug Administration requirements for vaccine safety and potency.
         Although Army owned the BW vaccines at the onset of operation
         Desert Shield, Army immediately made the stockpile available to the
         services to be used according to CENTCOM priorities.

             c.  @ Success was that the BW Vaccination Program for U.S.
itiated
                                                                e sent to the
         AOR for immunization of service members. More doses were scheduled



             d. (U) operation Desert Shield/Storm clearly showed that the
         vaccine production industrial base needs to be increased for both
         BW and endemic disease vaccines. CONUS vaccine production
         capabilities are decreasing because of low profits and high
         liabilities.


         CLASSIFIED BY: DASG-HCZ
         DECLASSIFY ON: OADR        DECLASSIFIED
                                    ON: 25 OCT 96
                                    BY: SEC ARMY (DAMH) UNDER SEC 3.4 EO 12958


                                                 UNCLASSIFIED

Document 2 f:/Week-36/BX003204/MEDICAL BIOLOGICAL WARFARE DEFENSE READINESS FOR US FORCES IN ODS/med bio warfare def readiness for us forces in o:1122961634175
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003204
Unit = OTSG
Parent Organization = HSC
Folder Title = MEDICAL BIOLOGICAL WARFARE DEFENSE READINESS FOR US FORCES IN ODS
Folder Seq # = 10
Subject = MED BIO WARFARE DEF READINESS FOR US FORCES IN O
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 22-NOV-1996